The aim of this study was to determine whether the proportion of circu
lating B cells expressing the differentiative antigen CD5 was increase
d in children affected by type 1 diabetes, and whether the number of t
hese cells was correlated with the presence of anti-islet cell autoant
ibodies. Sixteen children affected by insulin-dependent diabetes melli
tus (type 1) were investigated for the presence of B lymphocytes beari
ng the CD5 surface molecule, T-cell-specific activation markers, organ
- and nonorgan-specific autoantibodies. The number of CD5+CD19+ cells
was higher in type 1 children with a very recent onset of the disease,
as compared with patients on insulin therapy for more than 30 days an
d controls (P < 0.05). No correlation was found between the number of
CD5+CD19+ cells and the presence of either organ- or nonorgan-specific
autoantibodies. Our re suits indicate that CD5+CD19+ cells are involv
ed in the pathogenesis of type 1 diabetes in children. A potential imm
unoregulatory role of this B cell population is discussed.